Contattaci Contact Us

VGFM DATA-LAYER

Dettagli dell'Evento:

Moving from umbrella terms to therapeutic features in airway disease: a paradigm shift

18 novembre 2022 - Giorno 1

  • Welcome Addresses

    Relatore Markus Ollert

    Data Intervento 18/11/2022 - 08:46

  • Welcome Addresses - The reason for a meeting focused on treatable traits in airway diseases

    Relatore Mario Cazzola

    Data Intervento 18/11/2022 - 09:00

  • Is personalised medicine the key to heterogeneity in airway diseases?

    Relatore Peter J. Barnes

    Data Intervento 18/11/2022 - 09:15

  • Discussion 1

    Relatore -

    Data Intervento 18/11/2022 - 09:30

  • Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic airway diseases

    Relatore Anke-Hilse Maitland-Van der Zee

    Data Intervento 18/11/2022 - 09:50

  • Discussion 2

    Relatore -

    Data Intervento 18/11/2022 - 10:25

  • Treatable traits domains and criteria to be considered a trait

    Relatore Fabio Ricciardolo

    Data Intervento 18/11/2022 - 10:40

  • Discussion 3

    Relatore -

    Data Intervento 18/11/2022 - 10:50

  • Treatable traits as a way toward precision medicine of airway diseases

    Relatore Nicola Scichilone

    Data Intervento 18/11/2022 - 11:30

  • Discussion 4

    Relatore -

    Data Intervento 18/11/2022 - 12:05

  • The importance of the U-BIOPRED project in identifying treatable traits in asthma

    Relatore Kian Fan Chung

    Data Intervento 18/11/2022 - 12:15

  • Discussion 5

    Relatore -

    Data Intervento 18/11/2022 - 12:30

  • The search for new biomarkers to identify treatable traits in airway diseases

    Relatore D. Stolz

    Data Intervento 18/11/2022 - 12:40

  • Discussion 6

    Relatore -

    Data Intervento 18/11/2022 - 13:00

  • Precision medicine and treatable traits in asthma – where do we stand?

    Relatore Charlotte Suppli Ulrik

    Data Intervento 18/11/2022 - 14:15

  • Discussion 7

    Relatore -

    Data Intervento 18/11/2022 - 14:35

  • Can we consider T2high and T2low asthma as treatable traits?

    Relatore Nicola A. Hanania

    Data Intervento 18/11/2022 - 14:50

  • Discussion 8

    Relatore -

    Data Intervento 18/11/2022 - 15:05

  • Precision medicine in united airways disease: A treatable traits approach

    Relatore Tododr A. Popov

    Data Intervento 18/11/2022 - 16:20

  • Discussion 9

    Relatore -

    Data Intervento 18/11/2022 - 16:35

  • ACO: Time to move to the treatable traits

    Relatore Joan Soriano

    Data Intervento 18/11/2022 - 16:55

  • Discussion 10

    Relatore -

    Data Intervento 18/11/2022 - 17:15

  • Panel discussion - The Audience 30 Is there a need for a new taxonomy for airway diseases?

    Relatore Peter J. Barnes

    Data Intervento 18/11/2022 - 17:30

19 novembre 2022 - Giorno 2

  • Effectiveness of artificial intelligence for a treatable trait approach in airway diseases

    Relatore L. Calzetta

    Data Intervento 19/11/2022 - 09:00

  • Discussion 11

    Relatore -

    Data Intervento 19/11/2022 - 09:15

  • Alpha-1 antitrypsin deficiency: An underrecognized, treatable trait of airway diseases

    Relatore Miriam Barrecheguren

    Data Intervento 19/11/2022 - 09:35

  • Discussion 12

    Relatore -

    Data Intervento 19/11/2022 - 09:50

  • Are comorbidities treatable traits in airway diseases?

    Relatore Paola Rogliani

    Data Intervento 19/11/2022 - 10:10

  • Discussion 13

    Relatore -

    Data Intervento 19/11/2022 - 10:30

  • Lung microbiome as a treatable trait

    Relatore Andrea Bianco

    Data Intervento 19/11/2022 - 11:15

  • Discussion 14

    Relatore -

    Data Intervento 19/11/2022 - 11:40

  • In search of treatable traits of acute exacerbations of COPD

    Relatore A. G. Mathioudakis

    Data Intervento 19/11/2022 - 11:50

  • Discussion 15

    Relatore -

    Data Intervento 19/11/2022 - 12:15

  • Treatable traits in bronchiectasis

    Relatore C. Crimi

    Data Intervento 19/11/2022 - 12:25

  • Discussion 16

    Relatore -

    Data Intervento 19/11/2022 - 12:45

  • Airway smooth muscle as a treatable trait

    Relatore Maria Gabriella Matera

    Data Intervento 19/11/2022 - 14:00

  • Discussion 17

    Relatore -

    Data Intervento 19/11/2022 - 14:25

  • Eosinophils as a treatable trait

    Relatore Francesca Levi-Schaffer

    Data Intervento 19/11/2022 - 14:35

  • Discussion 18

    Relatore -

    Data Intervento 19/11/2022 - 15:00

  • Current and future targeted therapies for airway diseases

    Relatore Clive Page

    Data Intervento 19/11/2022 - 15:10

  • Diagnosis of stable COPD using the treatable traits concept based on clinical phenotypes

    Relatore Vladimir Koblizek

    Data Intervento 19/11/2022 - 16:15

  • Discussion 19

    Relatore -

    Data Intervento 19/11/2022 - 16:35

  • The use of treatable traits to address COPD complexity and heterogeneity

    Relatore Nicolas Roche

    Data Intervento 19/11/2022 - 16:45

  • Discussion 20

    Relatore -

    Data Intervento 19/11/2022 - 17:10

  • Precision medicine in COPD: from hope to disappointment

    Relatore Pierachille Santus

    Data Intervento 19/11/2022 - 17:15

  • Discussion 21

    Relatore -

    Data Intervento 19/11/2022 - 17:25

  • Treatable traits of airway disease using HRCT

    Relatore E. Kocova

    Data Intervento 19/11/2022 - 17:50

  • Discussion 22

    Relatore -

    Data Intervento 19/11/2022 - 18:15

  • Conclusion and farewell

    Relatore Vladimir Koblizek

    Data Intervento 19/11/2022 - 18:25

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Nuovi Progetti: MINUTI DIGITALE



Minuti Menarini Online

Abbonati gratis alla rivista cartacea



Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484